C
Carmem Bonfim
Researcher at Federal University of Paraná
Publications - 163
Citations - 3372
Carmem Bonfim is an academic researcher from Federal University of Paraná. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 28, co-authored 135 publications receiving 2686 citations.
Papers
More filters
Journal ArticleDOI
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
Navneet S. Majhail,Navneet S. Majhail,J. Douglas Rizzo,Stephanie J. Lee,Mahmoud Aljurf,Yoshiko Atsuta,Carmem Bonfim,Linda J. Burns,Naeem Chaudhri,Stella M. Davies,Shinichiro Okamoto,Adriana Seber,Gérard Socié,Jeff Szer,Maria Teresa Van Lint,John R. Wingard,André Tichelli +16 more
TL;DR: In this article, the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic hematopoietic cell transplantation (HCT) were provided.
Journal ArticleDOI
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study
Daniele Moratto,Silvia Giliani,Carmem Bonfim,Evelina Mazzolari,Alain Fischer,Hans D. Ochs,Andrew J. Cant,Adrian J. Thrasher,Morton J. Cowan,Michael H. Albert,Trudy N. Small,Sung-Yun Pai,Elie Haddad,Antonella Lisa,Sophie Hambleton,Mary Slatter,Marina Cavazzana-Calvo,Nizar Mahlaoui,Capucine Picard,Troy R. Torgerson,Lauri Burroughs,Adriana Koliski,José Zanis Neto,Fulvio Porta,Waseem Qasim,Paul Veys,Kristina Kavanau,Manfred Hönig,Ansgar Schulz,Wilhelm Friedrich,Luigi D. Notarangelo +30 more
TL;DR: In this article, the authors analyzed long-term outcome and donor cell engraftment in 194 patients with Wiskott-Aldrich syndrome (WAS) who have been treated by hematopoietic cell transplantation (HCT) in the period 1980-2009.
Journal ArticleDOI
Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment
Roberto Giugliani,Andressa Federhen,Maria Verónica Muñoz Rojas,Taiane Alves Vieira,Osvaldo Alfonso Pinto Artigalas,Louise Lapagesse de Camargo Pinto,Ana Cecília Azevedo,Angelina Xavier Acosta,Carmem Bonfim,Charles Marques Lourenço,Chong Ae Kim,Dafne Dain Gandelman Horovitz,Bonfim D,Denise Y. J. Norato,Diane Ruschel Marinho,Durval Batista Palhares,Emerson de Santana Santos,Erlane Marques Ribeiro,Eugênia Ribeiro Valadares,Guarany F,de Lucca Gr,Helena Pimentel,de Souza In,Correa J,José Carlos Soares de Fraga,José Eduardo Góes,Cabral Jm,Simionato J,Juan C. Llerena,Laura Bannach Jardim,Liane de Rosso Giuliani,da Silva Lc,Mara Lúcia Schmitz Ferreira Santos,Miguel A. M. Moreira,Marcelo Kerstenetzky,Márcia Gonçalves Ribeiro,Nicole Ruas,Patricia Martins Moura Barrios,Paulo Cesar Aranda,Rachel Sayuri Honjo,Raquel Boy,Ronaldo C. da Costa,Cristiano de Pádua Souza,Alcantara Ff,Avilla Sg,Simone Fagondes,A. M. Martins +46 more
TL;DR: This document summarizes the experience of the professionals involved, along with the data available in the international literature, bringing together and harmonizing the information available on the management of these severe and progressive diseases, thus disclosing new prospects for Brazilian patients affected by these conditions.
Journal ArticleDOI
Results of Unrelated Cord Blood Transplant in Fanconi Anemia Patients: Risk Factor Analysis for Engraftment and Survival
Eliane Gluckman,Vanderson Rocha,Irina Ionescu,Marc Bierings,Richard E. Harris,John E. Wagner,Joanne Kurtzberg,Martin A. Champagne,Carmem Bonfim,Marco A. Bittencourt,Philip Darbyshire,M.N. Fernández,Franco Locatelli,Ricardo Pasquini +13 more
TL;DR: Factors easily modifiable such as donor selection and a Fludarabine-containing regimen can considerably improve survival in FA patients given a UCBT, and are the basis for designing prospective protocols.
Journal ArticleDOI
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?
Juliana F Fernandes,Vanderson Rocha,Myriam Labopin,Bénédicte Neven,Despina Moshous,Andrew R. Gennery,Wilhelm Friedrich,Fulvio Porta,Cristina Díaz de Heredia,Donna A. Wall,Yves Bertrand,Paul Veys,Mary Slatter,Ansgar Schulz,Ka Wah Chan,Michael Grimley,Mouhab Ayas,Tayfun Güngör,Wolfram Ebell,Carmem Bonfim,Krzysztof Kałwak,Pierre Taupin,Pierre Taupin,Stéphane Blanche,H. Bobby Gaspar,Paul Landais,Paul Landais,Alain Fischer,Alain Fischer,Eliane Gluckman,Marina Cavazzana-Calvo,Marina Cavazzana-Calvo +31 more
TL;DR: For children with SCID and no HLA-identical sibling donor, both UCBT and MMRDT represent available HSC sources for transplantation with quite similar outcomes.